The groundbreaking approach of the medication represents a major development in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets dual pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide482938.eedblog.com/42293374/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment